These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19776089)

  • 1. Topical chemotherapy for ocular surface squamous neoplasia: current status.
    Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
    Br J Ophthalmol; 2010 May; 94(5):532-5. PubMed ID: 19776089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular surface squamous neoplasia: a standard of care survey.
    Stone DU; Butt AL; Chodosh J
    Cornea; 2005 Apr; 24(3):297-300. PubMed ID: 15778602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia.
    Rudkin AK; Muecke JS
    Br J Ophthalmol; 2011 Jul; 95(7):947-50. PubMed ID: 21252085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
    Sturges A; Butt AL; Lai JE; Chodosh J
    Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia.
    Paul S; Stone DU
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):647-9. PubMed ID: 22900896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications.
    Russell HC; Chadha V; Lockington D; Kemp EG
    Br J Ophthalmol; 2010 Oct; 94(10):1316-21. PubMed ID: 20530655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
    Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
    Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
    Viani GA; Fendi LI
    Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular surface squamous neoplasia after corneal graft.
    Ramasubramanian A; Shields CL; Sinha N; Shields JA
    Am J Ophthalmol; 2010 Jan; 149(1):62-5. PubMed ID: 19846060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mitomycin-C for treatment of partially-excised ocular surface squamous neoplasia.
    Rahimi F; Alipour F; Ghazizadeh Hashemi H; Hashemian MN; Mehrdad R
    Arch Iran Med; 2009 Jan; 12(1):55-9. PubMed ID: 19111031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study.
    Parrozzani R; Frizziero L; Trainiti S; Testi I; Miglionico G; Pilotto E; Blandamura S; Fassina A; Midena E
    Br J Ophthalmol; 2017 Aug; 101(8):1094-1099. PubMed ID: 27941046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.